News & Updates

Early resumption of antiplatelet therapy (APT) and anticoagulant therapy (ACT) ≤7 days after gastrointestinal bleeding (GIB) offers a favourable benefit–risk balance in patients with cardiovascular (CV) or cerebrovascular indications, according to a systematic review and meta-analysis conducted by researchers from the Chinese University of Hong Kong and Nanyang Technological University in Singapore.

Patients with hypertension and co-existing moderate-to-severe obstructive sleep apnoea‒hypopnoea syndrome (OSAHS) are susceptible to more severe coronary microvascular dysfunction and elevated levels of inflammatory markers, suggests a study.